SCHEMBL6249173

SCHEMBL6249173

CC1(C)CC=C(c2ccc(OCc3ccccc3)cc2)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 2/20 0.46
RARA P10276 5/20 0.43
RARB P10826 5/20 0.43
RARG P13631 5/20 0.43
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42
CYP2C19 P33261 1/20 0.42
PTGS2 P35354 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HIF1A Q16665 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
BRD4 O60885 1/20 0.41
CREBBP Q92793 1/20 0.41
MAOB P27338 3/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4506592 0.83 MAOB (0.45) GSTP1RARARARBRARGMAOB
SCHEMBL4510658 0.80 RARA (0.39) GSTP1RARARARBRARGGAA
SCHEMBL7874221 0.78 RARA (0.74) RARARARBRARGRXRANR2E1
SCHEMBL7811795 0.76 RARA (0.62) RARARARBRARGMAOBRAB9A
SCHEMBL6252785 0.72 RARB (0.41) RARARARBRARGRAB9APDK2
SCHEMBL29978578 0.70 GSTP1 (0.71) GSTP1LMNACYP1A2PTGS1SLC6A2
SCHEMBL197017 0.70 LMNA (0.72) GSTP1LMNACYP1A2PTGS1SLC6A2
SCHEMBL3140318 0.69 GSTP1 (0.46) GSTP1LMNACYP1A2PTGS1SLC6A2
SCHEMBL23483029 0.68 LMNA (0.69) GSTP1LMNACYP1A2PTGS1SLC6A2
SCHEMBL1096817 0.68 LMNA (0.69) GSTP1LMNACYP1A2PTGS1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565433-A2 NOVEL LIGANDS THAT ARE ANTAGONISTS OF RAR RECEPTORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS Galderma Research & Development, S.N.C. (FR) 2005-08-24 EP disclosed
WO-2004046096-A2 NOVEL LIGANDS THAT ARE ANTAGONISTS OF RAF RECEPTORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS GALDERMA RESEARCH & DEVELOPMENT,S.N.C. (FR) 2004-06-03 WO disclosed